Synopsis
0
USDMF
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
70
PharmaCompass offers a list of Clobetasone Butyrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clobetasone Butyrate manufacturer or Clobetasone Butyrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clobetasone Butyrate manufacturer or Clobetasone Butyrate supplier.
PharmaCompass also assists you with knowing the Clobetasone Butyrate API Price utilized in the formulation of products. Clobetasone Butyrate API Price is not always fixed or binding as the Clobetasone Butyrate Price is obtained through a variety of data sources. The Clobetasone Butyrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trimovate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimovate, including repackagers and relabelers. The FDA regulates Trimovate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimovate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimovate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimovate supplier is an individual or a company that provides Trimovate active pharmaceutical ingredient (API) or Trimovate finished formulations upon request. The Trimovate suppliers may include Trimovate API manufacturers, exporters, distributors and traders.
click here to find a list of Trimovate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trimovate Drug Master File in Japan (Trimovate JDMF) empowers Trimovate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trimovate JDMF during the approval evaluation for pharmaceutical products. At the time of Trimovate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trimovate suppliers with JDMF on PharmaCompass.
A Trimovate CEP of the European Pharmacopoeia monograph is often referred to as a Trimovate Certificate of Suitability (COS). The purpose of a Trimovate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trimovate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trimovate to their clients by showing that a Trimovate CEP has been issued for it. The manufacturer submits a Trimovate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trimovate CEP holder for the record. Additionally, the data presented in the Trimovate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trimovate DMF.
A Trimovate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trimovate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Trimovate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trimovate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trimovate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trimovate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trimovate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trimovate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trimovate suppliers with NDC on PharmaCompass.
Trimovate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimovate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimovate GMP manufacturer or Trimovate GMP API supplier for your needs.
A Trimovate CoA (Certificate of Analysis) is a formal document that attests to Trimovate's compliance with Trimovate specifications and serves as a tool for batch-level quality control.
Trimovate CoA mostly includes findings from lab analyses of a specific batch. For each Trimovate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimovate may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimovate EP), Trimovate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimovate USP).
